Compare LBRDK & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LBRDK | BAX |
|---|---|---|
| Founded | 2014 | 1931 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Cable & Other Pay Television Services | Medical/Dental Instruments |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.7B | 9.4B |
| IPO Year | N/A | N/A |
| Metric | LBRDK | BAX |
|---|---|---|
| Price | $47.64 | $18.60 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $25.67 |
| AVG Volume (30 Days) | 1.2M | ★ 8.3M |
| Earning Date | 11-05-2025 | 10-30-2025 |
| Dividend Yield | N/A | ★ 0.22% |
| EPS Growth | ★ 1.38 | N/A |
| EPS | ★ 5.51 | N/A |
| Revenue | $1,016,000,000.00 | ★ $11,023,000,000.00 |
| Revenue This Year | $8.37 | $5.20 |
| Revenue Next Year | $2.91 | $2.02 |
| P/E Ratio | $5.70 | ★ N/A |
| Revenue Growth | ★ 306.40 | 3.90 |
| 52 Week Low | $44.63 | $17.40 |
| 52 Week High | $104.00 | $37.74 |
| Indicator | LBRDK | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 43.00 | 43.20 |
| Support Level | $44.88 | $18.33 |
| Resistance Level | $46.77 | $19.17 |
| Average True Range (ATR) | 1.42 | 0.54 |
| MACD | 0.54 | 0.21 |
| Stochastic Oscillator | 82.05 | 63.23 |
Liberty Broadband Corp serves in the telecommunications industry in the United States. It provides cable services to both residential andsommercial businesses through its fiber, hybrid fiber, and coaxial cable infrastructure. The services provided by the company are residential services which include video services, internet services, voice services, and mobile services, commercial services which include small, and medium business and enterprise solutions, advertising services, and other services. The reportable segments of the company are GCI Holdings, Charter. The firm derives the majority of its revenue from GCI Holdings.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.